HALO logo
halo search icon
Zymeworks Inc.

US$24.84

Price Change Indicator
0.44 (1.80%)
Zymeworks Inc.
ZYME · NAS

Zymeworks Inc.

Start Trading ZYME for Free

US$24.84

Price Arrow0.44 (1.80%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapFakey Shakey - LongHALO AllHALO Balance SheetHALO Earnings MomentumHALO GARP+3
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Zymeworks Inc. Overview

ZYME Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Strong

Garp

Very Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About ZYME

icon
icon

Telephone

1.302.274.8744

icon

Address

Suite A, 108 Patriot Drive, Middletown, DE 19709

Description

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

ZYME Price Chart

Key Stats

Market Cap

US$1.78B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 11.02 - 29.75

Trade Value (12mth)

US$3,867,001.00

1 week

1.96%

1 month

-13.69%

YTD

-8.34%

1 year

104.36%

All time high

59.03

Key Fundamentals

EPS 3 yr Growth

-156.40%

EBITDA Margin

-77.20%

Operating Cashflow

-$33m

Free Cash Flow Return

-10.30%

ROIC

-25.40%

Interest Coverage

0.00

Quick Ratio

5.90

Other Data

Shares Outstanding (Fully Diluted)

75m

HALO Sector

Healthcare

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ZYME Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
08 May 26
08 May 26
08 May 26

ZYME Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.72-1.62-1.08locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.72-1.62-1.08locklocklock
Growth
 %locklocklocklock-190.46.133.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Zymeworks Inc. (ZYME:NAS)?
Halo FAQ
The current share price of Zymeworks Inc. (ZYME:NAS) is USD$24.84.
What is the 52-week high share price for Zymeworks Inc. (ZYME:NAS)?
Halo FAQ
The 52-week high share price for Zymeworks Inc. (ZYME:NAS) is USD$29.75.
What is the 52-week low share price for Zymeworks Inc. (ZYME:NAS)?
Halo FAQ
The 52-week low share price for Zymeworks Inc. (ZYME:NAS) is USD$11.02.
What is the dividend yield for Zymeworks Inc. (ZYME:NAS)?
Halo FAQ
Zymeworks Inc. (ZYME:NAS) does not pay a dividend.
What was Zymeworks Inc. (ZYME:NAS) last dividend payment?
Halo FAQ
Zymeworks Inc. (ZYME:NAS) does not pay a dividend.
What is the franking level for Zymeworks Inc. (ZYME:NAS)?
Halo FAQ
Zymeworks Inc. (ZYME:NAS) has a franking level of 0.00%.
In which sector is Zymeworks Inc. (ZYME:NAS) classified?
Halo FAQ
Zymeworks Inc. (ZYME:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial